HYDERABAD (Reuters) – Indian drugmaker Sun Pharmaceutical Industries posted fourth-quarter profit above estimates on Wednesday, helped by strong performance in its key U.S. and domestic markets.
The company’s net profit stood at 26.55 billion rupees ($318.9 million) for the three months ended March 31, against analysts’ average estimate of 23.68 billion rupees, according to LSEG data.
($1 = 83.2688 Indian rupees)
(Reporting by Rishika Sadam; Editing by Varun H K)
Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibilty for its content.